Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Sacks

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of Virological Methods|October 1, 1983
Serotyping of herpes simplex virus isolates: a comparison of BVDU sensitivities, indirect immunofluorescence with monoclonal antibodies, and indirect immunofluorescence with cross-adsorbed rabbit antibodiesS L Sacks, C Z Teh, L Lemchuk-Favel
Canadian Medical Association Journal|February 15, 1985
Neurotoxic effects during vidarabine therapy for herpes zosterD R Burdge, A W Chow, S L Sacks
Advances in Experimental Medicine and Biology|January 1, 1992
Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnetE Pelosi, K A Hicks, S L Sacks, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 1, 1994
No-carrier-added [123I]1-(beta-D-arabinofuranosyl)-5(E)-(2- iodovinyl)uracil (IVaraU): high yield radiolabeling via organotin and exchange reactionsH Dougan, B A Rennie, D M Lyster, et al.
The Journal of Clinical Investigation|January 1, 1982
Inactivation of S-adenosylhomocysteine hydrolase during adenine arabinoside therapyS L Sacks, T C Merigan, J Kaminska, et al.
Antiviral Research|September 1, 2001
Preclinical evaluation of docusate as protective agent from herpes simplex virusesY Gong, A Wen, D Cheung, et al.
Journal of Medicinal Chemistry|June 1, 1985
Synthesis and antiviral activity of 11-azapentacyclo[6.2.1.0.0.0]decaneS L Sacks, J R Scheffer, C Z Teh, et al.
Antiviral Research|June 1, 1985
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine creamD J Freeman, S L Sacks, E De Clercq, et al.
Journal of Chromatography|March 7, 1986
High-performance liquid chromatographic analysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine and its metabolites in serum, urine and herpes simplex virus type-1 infected cellsN K Ayisi, R A Wall, E De Clercq, et al.
AIDS (London, England)|July 1, 1995
Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella zoster virus infection in HIV-infected patientsD R Burdge, R Voigt, J I Lindley, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Virological Methods|October 1, 1983
Serotyping of herpes simplex virus isolates: a comparison of BVDU sensitivities, indirect immunofluorescence with monoclonal antibodies, and indirect immunofluorescence with cross-adsorbed rabbit antibodiesS L Sacks, C Z Teh, L Lemchuk-Favel
Canadian Medical Association Journal|February 15, 1985
Neurotoxic effects during vidarabine therapy for herpes zosterD R Burdge, A W Chow, S L Sacks
Advances in Experimental Medicine and Biology|January 1, 1992
Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnetE Pelosi, K A Hicks, S L Sacks, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 1, 1994
No-carrier-added [123I]1-(beta-D-arabinofuranosyl)-5(E)-(2- iodovinyl)uracil (IVaraU): high yield radiolabeling via organotin and exchange reactionsH Dougan, B A Rennie, D M Lyster, et al.
The Journal of Clinical Investigation|January 1, 1982
Inactivation of S-adenosylhomocysteine hydrolase during adenine arabinoside therapyS L Sacks, T C Merigan, J Kaminska, et al.
Antiviral Research|September 1, 2001
Preclinical evaluation of docusate as protective agent from herpes simplex virusesY Gong, A Wen, D Cheung, et al.
Journal of Medicinal Chemistry|June 1, 1985
Synthesis and antiviral activity of 11-azapentacyclo[6.2.1.0.0.0]decaneS L Sacks, J R Scheffer, C Z Teh, et al.
Antiviral Research|June 1, 1985
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine creamD J Freeman, S L Sacks, E De Clercq, et al.
Journal of Chromatography|March 7, 1986
High-performance liquid chromatographic analysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine and its metabolites in serum, urine and herpes simplex virus type-1 infected cellsN K Ayisi, R A Wall, E De Clercq, et al.
AIDS (London, England)|July 1, 1995
Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella zoster virus infection in HIV-infected patientsD R Burdge, R Voigt, J I Lindley, et al.
Pageof 6